We are live on ! Find out more
CLPT icon

ClearPoint Neuro

50 hedge funds and large institutions have $65.6M invested in ClearPoint Neuro in 2021 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 18 increasing their positions, 6 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

4,725% more call options, than puts

Call options by funds: $579K | Put options by funds: $12K

217% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 6

200% more repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 6

81% more capital invested

Capital invested by funds: $36.1M → $65.6M (+$29.4M)

28% more funds holding

Funds holding: 3950 (+11)

1.53% more ownership

Funds ownership: 13.48%15.01% (+1.5%)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

Holders
50
Holders Change
+11
Holders Change %
+28.21%
% of All Funds
0.88%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.04%
New
19
Increased
18
Reduced
6
Closed
6
Calls
$579K
Puts
$12K
Net Calls
+$567K
Net Calls Change
+$567K
Name Holding Trade Value Shares
Change
Change in
Stake
CM
51
CM Management
Florida
-$3.34M -210,000 Closed
EI
52
EAM Investors
California
-$1.68M -105,928 Closed
6CM
53
683 Capital Management
New York
-$329K -20,690 Closed
MWM
54
Merriman Wealth Management
Washington
-$168K -10,560 Closed
Bank of New York Mellon
55
Bank of New York Mellon
New York
-$163K -10,255 Closed
ASN
56
Advisory Services Network
Georgia
-$6K -400 Closed

CLPT Hedge Fund Activity: Q1 2021 in Review

50 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in ClearPoint Neuro (CLPT) for Q1 2021, worth a combined $65.6M — up 81% from $36.1M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new CLPT positions and 6 closed out — a net gain of 13 holders — while 18 added to existing stakes and 6 trimmed.

The largest buyer was BlackRock, adding an estimated $5.82M. The largest seller was CM Management, exiting entirely with an estimated $3.34M sold.

  • 50 institutional investors held ClearPoint Neuro (CLPT) as of Q1 2021, up from 39 in Q4 2020.
  • Funds reported $65.6M of ClearPoint Neuro stock for Q1 2021, up 81% quarter-over-quarter.
  • 19 funds opened new ClearPoint Neuro positions in Q1 2021 and 6 closed out, a net change of +13 holders.
  • The largest ClearPoint Neuro buyer in Q1 2021 was BlackRock, an estimated $5.82M added.
  • The largest ClearPoint Neuro seller in Q1 2021 was CM Management, an estimated $3.34M sold.

Based on aggregated 13F filings for Q1 2021.